Skip to menu Skip to content Skip to footer

2022

Journal Article

Therapeutic drug monitoring and prolonged infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa infections: An observational study

Navarrete-Rouco, María Eugenia, Luque, Sònia, Sorlí, Luisa, Benítez-Cano, Adela, Roberts, Jason A. and Grau, Santiago (2022). Therapeutic drug monitoring and prolonged infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa infections: An observational study. European Journal of Drug Metabolism and Pharmacokinetics, 47 (4), 561-566. doi: 10.1007/s13318-022-00772-x

Therapeutic drug monitoring and prolonged infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa infections: An observational study

2022

Journal Article

Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients

Setiawan, Eko, Abdul-Aziz, Mohd-Hafiz, Cotta, Menino Osbert, Susaniwati, Susaniwati, Cahjono, Heru, Sari, Ika Yunita, Wibowo, Tjipto, Marpaung, Ferdy Royland and Roberts, Jason A. (2022). Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients. Scientific Reports, 12 (1) 8930, 1-11. doi: 10.1038/s41598-022-12627-1

Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients

2022

Journal Article

Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document

Sime, Fekade Bruck, Wallis, Steven, Jamieson, Conor, Hills, Tim, Gilchrist, Mark, Santillo, Mark, Seaton, R Andrew, Drummond, Felicity and Roberts, Jason (2022). Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document. European Journal of Hospital Pharmacy, 30 (e1), ejhpharm-2022. doi: 10.1136/ejhpharm-2022-003286

Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document

2022

Journal Article

Multicenter population pharmacokinetic study of unbound ceftriaxone in critically ill patients

Heffernan, Aaron J., Sime, Fekade B., Kumta, Nilesh, Wallis, Steven C., McWhinney, Brett, Ungerer, Jacobus, Wong, Gloria, Joynt, Gavin M., Lipman, Jeffrey and Roberts, Jason A. (2022). Multicenter population pharmacokinetic study of unbound ceftriaxone in critically ill patients. Antimicrobial Agents and Chemotherapy, 66 (6), e0218921. doi: 10.1128/aac.02189-21

Multicenter population pharmacokinetic study of unbound ceftriaxone in critically ill patients

2022

Journal Article

Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis

Ezure, Yukiko, Rico, Veronica, Paterson, David L., Hall, Lisa, Harris, Patrick N. A., Soriano, Alex, Roberts, Jason A., Bassetti, Matteo, Roberts, Matthew J., Righi, Elda and Wright, Hugh (2022). Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis. Open Forum Infectious Diseases, 9 (5) ofaa480, ofaa480. doi: 10.1093/ofid/ofaa480

Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis

2022

Journal Article

Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically-ill patients

Wicha, Sebastian G., Mair, Andrea, Chiriac, Ute, Frey, Otto R., Fuchs, Thomas, Gaasch, Max, Hagel, Stefan, Richter, Daniel C., Roberts, Jason A., Röhr, Anka C., Weigand, Markus A. and Brinkmann, Alexander (2022). Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically-ill patients. International Journal of Antimicrobial Agents, 59 (5) 106572, 106572. doi: 10.1016/j.ijantimicag.2022.106572

Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically-ill patients

2022

Journal Article

Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (Intensive Care Medicine, (2022), 48, 3, (311-321), 10.1007/s00134-021-06609-6)

Hagel, Stefan, Bach, Friedhelm, Brenner, Thorsten, Bracht, Hendrik, Brinkmann, Alexander, Annecke, Thorsten, Hohn, Andreas, Weigand, Markus Alexander, Michels, Guido, Kluge, Stefan, Nierhaus, Axel, Jarczak, Dominik, König, Christina, Weismann, Dirk, Frey, Otto, Witzke, Dominic, Müller, Carsten, Bauer, Michael, Kiehntopf, Michael, Neugebauer, Sophie, Lehmann, Thomas, Roberts, Jason A., Pletz, Mathias W., Braune, Anke, Schmidt, Karsten, Motsch, Johann, Pinder, Nadine, Richter, Daniel, Schlattmann, Peter ... Chkirni, Hicham (2022). Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (Intensive Care Medicine, (2022), 48, 3, (311-321), 10.1007/s00134-021-06609-6). Intensive Care Medicine, 48 (5), 646-647. doi: 10.1007/s00134-022-06668-3

Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (Intensive Care Medicine, (2022), 48, 3, (311-321), 10.1007/s00134-021-06609-6)

2022

Journal Article

Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

Avent, Minyon L., McCarthy, Kate L., Sime, Fekade B., Naicker, Saiyuri, Heffernan, Aaron J., Wallis, Steven C., Paterson, David L. and Roberts, Jason A. (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. Microbiology Spectrum, 10 (3), e0052522. doi: 10.1128/spectrum.00525-22

Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

2022

Journal Article

Use of the hollow-fiber infection model to measure the effect of combination therapy of septic shock exposures of Meropenem and Ciprofloxacin against intermediate and resistant Pseudomonas aeruginosa clinical Isolates

Karabasevic, Natalija, Roberts, Jason A., Stronach, Luke, Naicker, Saiyuri, Wallis, Steven C., Sjövall, Fredrik and Sime, Fekade (2022). Use of the hollow-fiber infection model to measure the effect of combination therapy of septic shock exposures of Meropenem and Ciprofloxacin against intermediate and resistant Pseudomonas aeruginosa clinical Isolates. Antimicrobial Agents and Chemotherapy, 66 (5) e0214021, e0214021. doi: 10.1128/aac.02140-21

Use of the hollow-fiber infection model to measure the effect of combination therapy of septic shock exposures of Meropenem and Ciprofloxacin against intermediate and resistant Pseudomonas aeruginosa clinical Isolates

2022

Journal Article

Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective

Giacobbe, Daniele Roberto, Roberts, Jason A., Abdul-Aziz, Mohd H., de Montmollin, Etienne, Timsit, Jean-François and Bassetti, Matteo (2022). Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective. Expert Review of Anti-infective Therapy, 20 (7), 1-17. doi: 10.1080/14787210.2022.2063838

Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective

2022

Journal Article

Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum?

Coombes, Ian D., Legg, Amy, Patterson, Tina, Kelly, Tanya, Henderson, Andrew and Roberts, Jason A. (2022). Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum?. Australian Prescriber, 45 (2), 67-68. doi: 10.18773/austprescr.2022.021

Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum?

2022

Journal Article

Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients

Sulaiman, Helmi, Roberts, Jason A. and Abdul-Aziz, Mohd H. (2022). Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients. Farmacia Hospitalaria, 46 (3), 182-190. doi: 10.7399/fh.13170

Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients

2022

Journal Article

Population pharmacokinetic model of piperacillin in critically ill patients and describing interethnic variation using external validation

Sanches, Cristina, Alves, Geisa C. S., Farkas, Andras, da Silva, Samuel Dutra, de Castro, Whocely Victor, Chequer, Farah Maria Drummond, Beraldi-Magalhães, Francisco, Magalhães, Igor Rafael dos Santos, Baldoni, André de Oliveira, Chatfield, Mark D., Lipman, Jeffrey, Roberts, Jason A. and Parker, Suzanne L. (2022). Population pharmacokinetic model of piperacillin in critically ill patients and describing interethnic variation using external validation. Antibiotics, 11 (4) 434, 434. doi: 10.3390/antibiotics11040434

Population pharmacokinetic model of piperacillin in critically ill patients and describing interethnic variation using external validation

2022

Journal Article

Hospital-based antimicrobial stewardship programs used in low- and middle-income countries: a scoping review

Setiawan, Eko, Abdul-Aziz, Mohd-Hafiz, Roberts, Jason A. and Cotta, Menino Osbert (2022). Hospital-based antimicrobial stewardship programs used in low- and middle-income countries: a scoping review. Microbial Drug Resistance, 28 (5), 566-584. doi: 10.1089/mdr.2021.0363

Hospital-based antimicrobial stewardship programs used in low- and middle-income countries: a scoping review

2022

Journal Article

Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipient

Whitmore, Timothy J., Cheng, Vesa, Rawlins, Matthew D., Morgan, David, Chang, Tim, O'Halloran, Sean, Dyer, John R., Boan, Peter and Roberts, Jason A. (2022). Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipient. Transplant Infectious Disease, 24 (2) e13818, e13818. doi: 10.1111/tid.13818

Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipient

2022

Journal Article

Population pharmacokinetics and dosing simulations of ceftriaxone in critically ill patients receiving extracorporeal membrane oxygenation (An ASAP ECMO Study)

Cheng, Vesa, Abdul-Aziz, Mohd H., Burrows, Fay, Buscher, Hergen, Cho, Young-Jae, Corley, Amanda, Gilder, Eileen, Kim, Hyung-Sook, Lim, Sung Yoon, McGuinness, Shay, Parke, Rachael, Reynolds, Claire, Rudham, Sam, Wallis, Steven C., Welch, Susan A., Fraser, John F., Shekar, Kiran, Roberts, Jason A. and ASAP ECMO Investigators (2022). Population pharmacokinetics and dosing simulations of ceftriaxone in critically ill patients receiving extracorporeal membrane oxygenation (An ASAP ECMO Study). Clinical Pharmacokinetics, 61 (6), 847-856. doi: 10.1007/s40262-021-01106-x

Population pharmacokinetics and dosing simulations of ceftriaxone in critically ill patients receiving extracorporeal membrane oxygenation (An ASAP ECMO Study)

2022

Journal Article

Influence of PEGylated porous silicon nanoparticles on permeation and efflux of an orally administered antibiotic

Raza, A., Kamato, D., Sime, F.B., Roberts, J.A., Popat, A., Falconer, J.R. and Kumeria, T. (2022). Influence of PEGylated porous silicon nanoparticles on permeation and efflux of an orally administered antibiotic. Materials Today Advances, 13 100210, 100210. doi: 10.1016/j.mtadv.2022.100210

Influence of PEGylated porous silicon nanoparticles on permeation and efflux of an orally administered antibiotic

2022

Journal Article

Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model

Abbott, Iain J., van Gorp, Elke, Wyres, Kelly L., Wallis, Steven C., Roberts, Jason A., Meletiadis, Joseph and Peleg, Anton Y. (2022). Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model. Journal of Antimicrobial Chemotherapy, 77 (5), 1324-1333. doi: 10.1093/jac/dkac045

Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model

2022

Journal Article

Indonesian healthcare providers' perceptions and attitude on antimicrobial resistance, prescription and stewardship programs

Setiawan, Eko, Cotta, Menino O., Abdul-Aziz, Mohd Hafiz, Sosilya, Hernycane, Widjanarko, Doddy, Wardhani, Dian K. and Roberts, Jason A. (2022). Indonesian healthcare providers' perceptions and attitude on antimicrobial resistance, prescription and stewardship programs. Future Microbiology, 17 (5), 363-375. doi: 10.2217/fmb-2021-0193

Indonesian healthcare providers' perceptions and attitude on antimicrobial resistance, prescription and stewardship programs

2022

Journal Article

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Hagel, Stefan, Bach, Friedhelm, Brenner, Thorsten, Bracht, Hendrik, Brinkmann, Alexander, Annecke, Thorsten, Hohn, Andreas, Weigand, Markus, Michels, Guido, Kluge, Stefan, Nierhaus, Axel, Jarczak, Dominik, König, Christina, Weismann, Dirk, Frey, Otto, Witzke, Dominic, Müller, Carsten, Bauer, Michael, Kiehntopf, Michael, Neugebauer, Sophie, Lehmann, Thomas, Roberts, Jason A., Pletz, Mathias W., Braune, Anke, Schmidt, Karsten, Motsch, Johann, Pinder, Nadine, Richter, Daniel, Schlattmann, Peter ... Chkirni, Hicham (2022). Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Medicine, 48 (3), 311-321. doi: 10.1007/s00134-021-06609-6

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial